Latest tuberculosis Stories

A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) — a disease that kills 2 million people annually — a scientist reported today at the 243 National Meeting & Exposition of the American Chemical Society (ACS). The treatment, which combines two medications already approved by the U.S. Food and Drug Administration (FDA), delivers a knockout punch to forms of TB that shrug off other antibiotics. ACS, the world's largest...

FRANKLIN LAKES, N.J., March 27, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) and FIND (Foundation for Innovative New Diagnostics) have announced a new collaboration to promote access to early and accurate diagnosis of multidrug-resistant tuberculosis (MDR-TB) among HIV-infected patients and other vulnerable populations in India, a country that accounts for nearly 25 percent of TB cases globally. The 18-month program will focus on increasing the number of...

Looking at the current state of TB knowlege and new cases we have come a long way, but dont think that this is over. Cleveland, OH (PRWEB) March 24, 2012 Consequences of Underfunding TB "Looking at the current state of TB knowledge and new cases we have come a long way, but don't think that this is over," says Alex Frankel director of whatistbweb.com. "We really believe that the internet has allowed us to cover more ground quickly and get the message out." Decline in burden of TB "In many...

WHO-endorsed test deployed in battle against tuberculosis in Malawi. Millwood, VA (PRWEB) March 23, 2012 On World TB Day, global NGO Project HOPE says new technology has the potential to revolutionize the speedy and accurate diagnosis of tuberculosis, one of the deadliest public health threats which claims about six million lives each year. About one-third of the world’s population is infected with Mycobacterium tuberculosis (MTb), the bacterium that causes TB. Tuberculosis is...

(Ivanhoe Newswire) – New, more effective vaccines will be decisive in the fight against TB. More than 10 million children have been orphaned by the disease, which is rapidly becoming resistant to available treatment options. Top scientific experts, all over the world, are working together to develop a vaccine that will eliminate TB on all fronts and levels. To address the many challenges posed by TB, ideal vaccine regimens must protect babies at birth from childhood TB, and prevent...

Public-Private Partnerships Play Integral Role in Worldwide Effort to Provide Access to Lifesaving Prevention, Treatment and Care WASHINGTON, March 20, 2012 /PRNewswire-USNewswire/ -- At a public event today on Capitol Hill, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Friends of the Global Fight Against AIDS, Tuberculosis and Malaria spotlighted the contributions of public-private partnerships to the Global Fund's lifesaving work. From assistance in drug delivery, to...

WASHINGTON, March 20, 2012 /PRNewswire-USNewswire/ -- Today, the U.S. Agency for International Development (USAID) released its annual report to Congress on U.S. Government (USG) international foreign assistance for tuberculosis (TB) control. The report documents the significant progress that has been made toward Global Health Initiative (GHI) TB targets through sustained and well-focused investments. The USG, in partnership with developing country National TB Control...

In the past decade, scientists have made significant progress building the critical knowledge and infrastructure needed to identify and develop novel tuberculosis (TB) vaccine candidates and move the most promising ones into human clinical trials. The results of those trials, coupled with advances from other TB studies, have paved the way for the next 10 years of research on TB vaccines, a critical component of TB control efforts, note scientists at the National Institute of Allergy and...

Field-wide effort builds consensus for path forward Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis, the strategic blueprint for the TB vaccine field represents consensus reached by the TB vaccine community. “The TB Vaccine Blueprint provides...

NEW BRUNSWICK, N.J., March 14, 2012 /PRNewswire-USNewswire/ -- The Foundation of UMDNJ, an affiliate of New Jersey Health Foundation, has received a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation's Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world. With the grant, Dr. David Alland, professor of medicine, chief...